Walleye Capital LLC Glaukos Corp Call Options Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$113.62 - $135.39 $159,068 - $189,545	-1,400 Reduced 42.42%	1,900 $247,000
Q2 2024 Aug 14, 2024	BUY	$89.48 - $118.35 $277,388 - $366,885	3,100 Added 1550.0%	3,300 $390,000
Q1 2024 May 15, 2024	BUY	$76.4 - $96.33 $15,280 - $19,266	200 New	200 $18,000
Q3 2023 Nov 14, 2023	BUY	$69.23 - $79.09 $387,688 - $442,904	5,600 New	5,600 $421,000

342

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.47B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.